Discuss This Drug

Hyaluronidase

CHEBI:CHEBI_750023

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
hyaluronidase
rxcui
630939
product_type
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
marketing_start_date
20041026
package_marketing_start_date
20041026
route
SUBCUTANEOUS
marketing_category
BULK INGREDIENT
labeler_name
Antares Pharma, Inc.
manufacturer_name
Antares Pharma, Inc.
active_ingredient_strength
150 [USP'U]/mL
active_ingredient_name
HYALURONIDASE
unii
8KOG53Z5EM
nui
M0009499
pharm_class_epc
Endoglycosidase [EPC]
pharm_class
Glycoside Hydrolases [CS]
pharm_class_cs
Glycoside Hydrolases [CS]
brand_name
AMPHADASE
brand_name_base
AMPHADASE
product_ndc
52221-201
application_number
BLA021665
spl_id
8d23e49b-6640-4614-9c4f-912aed931839
package_ndc
52221-201-00
package_description
1 BAG in 1 CAN (52221-201-00) / 1 kg in 1 BAG
spl_set_id
8396ea96-7cb5-4e26-87a4-90bca9c3c6dd
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class